MEDNAX (MD) Reports In-Line Q3 EPS, Guides Q4 Below Consensus

MEDNAX (NYSE: MD) reported Q3 EPS of $1.10, in-line with the analyst estimate of $1.10. Revenue for the quarter came in at $722.3 million versus the consensus estimate of $730.63 million.

MEDNAX sees Q4 2015 EPS of $1.10-$1.14, versus the consensus of $1.16.

For earnings history and earnings-related data on MEDNAX (MD) click here.

You May Also Be Interested In

• IDT Corp. (IDT) Tops Q3 EPS by 2c; offer guidance
• Broadcom results, guidance beat on soaring AI chip sales; stock slips after hours
• Macy's (M) Tops Q1 EPS by 10c, Beats on Revenue; Offers FY27 Guidance